This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pediatric Ophthalmology  • Retinal/ Chorioretinal Disorders  • Vitreoretinal Surgery  • Prognosis/ Outcomes  • Articles for Residents  • Alert me on articles by topic  Social Bookmarking   What's this?

Rohit R. Lakhanpal, MD; Regina L. Sun, MD; Thomas A. Albini, MD; Robert Coffee, MD, MPH; David K. Coats, MD; Eric R. Holz, MD

Arch Ophthalmol. 2006;124:675-679.

Objective  To assess the visual acuity of eyes successfully treated with 3-port lens-sparing vitrectomy for stage 4 retinopathy of prematurity.

Methods  Of 102 consecutive eyes achieving at least posterior pole reattachment, 30 eyes of 26 patients were tested by Teller or Allen acuity measurements and were subsequently converted to logarithm of the minimum angle of resolution (logMAR). Visual outcomes were also examined as either favorable or unfavorable (Snellen equivalent >20/200).

Results  Seventy-two eyes were not tested because of either inability to perform testing (age or neurologic sequelae related to prematurity) or loss of follow-up. Of those tested, mean ± SD logMAR visual acuity for the stage 4A and stage 4B groups was 0.51 ± 0.09 (Snellen approximate 20/62) and 1.03 ± 0.19 (Snellen approximate 20/200), respectively (odds ratio, 0.39; 95% confidence interval, 0.24-0.64; P = .001). Of those eyes assessed by Teller measurements, 10 of 10 stage 4A eyes and 3 (37.5%) of 8 stage 4B eyes had favorable outcomes; among eyes assessed with Allen measurements, 4 of 4 stage 4A eyes and 0 of 8 stage 4B eyes had favorable outcomes.

Conclusions  The majority of eyes were not tested. Among eyes tested after successful 3-port lens-sparing vitrectomy, some eyes treated prior to macular detachment may be associated with a more favorable outcome and improved maintenance of functional visual acuity.

Author Affiliations: Section of Vitreoretinal Diseases and Surgery, Baylor College of Medicine, Houston, Tex.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study
Kusaka et al.
Br J Ophthalmol 2008;92:1450-1455.
ABSTRACT | FULL TEXT